Bio City completes construction of a strategic logistics centre at VCIIP

The logistics centre of the Stem Cell Research Center, a company belonging to the Northway group of companies and the Northway Biotech cluster, has been completed within the Bio City III complex currently being developed at the Vilnius City Innovation Industrial Park (VCIIP).

“The logistics centre completed in nine months represents another significant milestone in expanding the infrastructure of our biotechnology campus, Bio City, and in creating conditions for further development,” says Prof. Vladas Algirdas Bumelis, Founder and Chairman of the Board of the Northway group of companies.

default

Construction Completed in Just 9 Months

The 1,700 sq. m A++ energy efficiency class logistics centre at the Vilnius City Innovation Industrial Park was started to build in February 2025. According to Tadas Grincevičius, Head of construction company Naresta, although the two-storey building is formally classified as a storage facility, its function is significantly broader.
“It includes office space, a precisely planned storage area, and high-grade ISO 8 cleanroom facilities with laminar airflow zones, overpressure solutions, and a controlled access airlock. This is a complex, multi-technology facility requiring extremely precise design and impeccable construction quality,” says Grincevičius.

The ISO 8 cleanroom facilities were among the most technically challenging aspects of the project, as they must maintain an exceptionally clean and stable environment. In such spaces, airborne particle levels are strictly controlled, airflow is managed, positive pressure is maintained, and all walls, ceilings, and surfaces must be fully airtight, easy to clean, and resistant to dust accumulation.

The logistics centre will be powered by remotely supplied green energy, further enhancing its environmental sustainability.

A Modern Ecosystem in Development

This building represents the first phase of the planned Stem Cell Research Center complex at the Vilnius City Innovation Industrial Park. The company also plans to establish a stem cell, tissue and organ engineering and 3D bioprinting centre, with a large-scale microbial process manufacturing centre to follow at a later stage.

According to Dr. Gediminas Pauliukevičius, CEO of Northtown Vilnius, Lithuania can truly be proud of the achievements and potential of its life sciences industry. However, in order to enable the sector to continue growing and competing globally, new infrastructure essential for its development must be created.

“The expansion of industry leaders such as Northway Biotech within VCIIP significantly strengthens the innovation park’s ecosystem, where synergy between science and business is crucial. Projects like this encourage industry growth, the development and implementation of innovations, and attract the attention of the international scientific and business communities to Vilnius,” says Dr. Pauliukevičius.

He notes that several high-tech companies are already operating within the VCIIP area, and that more than 20 companies—primarily in the life sciences sector—are expected to be fully established there over the next three years.